Drug safety ministry revokes license of arthritis drug Invossa for mislabeling cell ingredient
- 5 years ago
식약처, '인보사' 허가취소 확정… 코오롱 "소송 진행"
South Korea's drug safety ministry says it is revoking the license of gene therapy drug Invossa, effective next Tuesday,... after its maker was found to have mislabeled the active ingredient.
A treatment for knee arthritis,... the drug firm claimed Invossa is made from cartilage cells,... but it's been found that the cells were derived from kidneys,... and could develop into cancer.
The ministry said the drug firm Kolon Life Science... failed to explain why the cell ingredient is different from what they labeled... at a hearing in mid-June.
The company said it will file a complaint to protest the ministry's decision.
South Korea's drug safety ministry says it is revoking the license of gene therapy drug Invossa, effective next Tuesday,... after its maker was found to have mislabeled the active ingredient.
A treatment for knee arthritis,... the drug firm claimed Invossa is made from cartilage cells,... but it's been found that the cells were derived from kidneys,... and could develop into cancer.
The ministry said the drug firm Kolon Life Science... failed to explain why the cell ingredient is different from what they labeled... at a hearing in mid-June.
The company said it will file a complaint to protest the ministry's decision.